Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia.
about
Pediatric medulloblastoma - update on molecular classification driving targeted therapiesMedulloblastoma outcome is adversely associated with overexpression of EEF1D, RPL30, and RPS20 on the long arm of chromosome 8Biological background of pediatric medulloblastoma and ependymoma: a review from a translational research perspectiveMedulloblastoma: tumorigenesis, current clinical paradigm, and efforts to improve risk stratificationCerebellum development and medulloblastomaDevelopment and cancer of the cerebellumA gene expression signature predicts survival of patients with stage I non-small cell lung cancerIsochromosome breakpoints on 17p in medulloblastoma are flanked by different classes of DNA sequence repeatsFunctional and molecular interactions between the HGF/c-Met pathway and c-Myc in large-cell medulloblastoma.Signaling pathways in medulloblastoma.Quantitative mRNA expression analysis of neurotrophin-receptor TrkC and oncogene c-MYC from formalin-fixed, paraffin-embedded primitive neuroectodermal tumor samples.Anti-proliferative activity of the quassinoid NBT-272 in childhood medulloblastoma cellsRNA interference-mediated c-MYC inhibition prevents cell growth and decreases sensitivity to radio- and chemotherapy in childhood medulloblastoma cells.CRX is a diagnostic marker of retinal and pineal lineage tumorsBRAF activation induces transformation and then senescence in human neural stem cells: a pilocytic astrocytoma model.Genetic alterations in microRNAs in medulloblastomas.Polycomb genes expression as a predictor of poor clinical outcome in children with medulloblastoma.Abnormal expression of REST/NRSF and Myc in neural stem/progenitor cells causes cerebellar tumors by blocking neuronal differentiation.Histology predicts a favorable outcome in young children with desmoplastic medulloblastoma: a report from the children's oncology group.Molecular subgroups of medulloblastoma.Prognostic classification of pediatric medulloblastoma based on chromosome 17p loss, expression of MYCC and MYCN, and Wnt pathway activation.The micro-RNA 199b-5p regulatory circuit involves Hes1, CD15, and epigenetic modifications in medulloblastoma.Myc proteins in brain tumor development and maintenance.MB3W1 is an orthotopic xenograft model for anaplastic medulloblastoma displaying cancer stem cell- and Group 3-propertiesThe molecular classification of medulloblastoma: driving the next generation clinical trials.Distinct neural stem cell populations give rise to disparate brain tumors in response to N-MYC.Prognosis-related molecular markers in pediatric central nervous system tumors.Novel cell lines established from pediatric brain tumors.A statin-regulated microRNA represses human c-Myc expression and function.Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variablesCurrent concepts in the molecular genetics of pediatric brain tumors: implications for emerging therapies.Molecular diagnostics in embryonal brain tumors.Pathogenesis of medulloblastoma and current treatment outlook.Genetic grouping of medulloblastomas by representative markers in pathologic diagnosis.Aggressive infantile embryonal tumors.Childhood brain tumors: accomplishments and ongoing challenges.Neural stem cells, inflammation and NF-kappaB: basic principle of maintenance and repair or origin of brain tumours?REST is a novel prognostic factor and therapeutic target for medulloblastomaTreatment Options for Medulloblastoma and CNS Primitive Neuroectodermal Tumor (PNET)Advances in the management of pediatric central nervous system tumors.
P2860
Q21129295-3FCBAD59-E148-4C0A-BD8B-D733D8978460Q21260423-1B842EAD-300D-4C50-AF55-13403DE6409AQ24658389-A498DF88-1BFA-4067-A8C6-F6DD3F705E74Q28299667-CD05830E-F7CA-447E-9685-F7176A4F12ABQ28304753-5F98CC91-E4A8-42EE-B4E3-D49320739C7FQ28305235-E2354CCA-3EDE-4B20-A8EA-4E5566F4DA01Q28764568-3843EA4E-D7A5-4817-8DC5-18B97F8257E3Q29037387-3EE8DF54-C836-4BE5-91E7-B06944C74ACDQ30445148-D22FE968-135B-4CCA-B19B-90A4DF705AD3Q30446635-D1CF657A-6829-48D3-BAB0-65E39A4A476EQ33262451-7499C005-89BE-4207-A0A4-FF74B8D0520FQ33270402-23001741-2C1C-45AA-B655-3E4753F57C4CQ33398834-ED1C921F-AD20-4C24-AE10-136263AD2770Q33516561-73050E3F-4815-4D04-AB48-87ABF3634299Q33862879-886F04E1-DA67-42DD-A7ED-0082407CA3F6Q34203950-AB22CABD-2052-4E31-8A6C-E4445929DAF0Q34462864-913A89B1-F5F2-4943-A93C-9DEAD68F41DFQ34519687-C2D371EF-CFB9-4DF5-BA9E-BFCF1D01A10EQ35058988-0508690B-B4F9-4BD1-89E4-84DD27966DBCQ35101347-39995363-B0D0-4D1B-8B2F-389328F539F6Q35696363-BD808E2F-059B-48A0-A780-3E1D4C1BB141Q35914487-D882FFF5-DFD3-4156-B9E7-CDBE11068F3DQ35920494-8F6D37B3-5418-4D79-8867-F32F37F7D04FQ35925281-0EEE6B43-E2DC-499E-96A5-BD1FEA3115E7Q35946293-FCB8D0F9-38B3-4B87-8C96-FCCF7A3C2DFDQ35989886-054223D0-F053-4ADC-A169-29DDE1A187F3Q35996275-BA13BBCE-C909-4310-BBE7-B2D4A8681BE7Q36047046-E1103373-97C8-4A49-B5A9-0D5C895947F3Q36379501-D4F4F52B-50FD-4193-8498-8B767FC3B0FAQ36476670-952F9AFC-F850-436B-8611-17F5621A0787Q36585123-2818C278-4F62-44A1-ACA4-FE86A9670B05Q36619093-AC5552C2-2E5B-48C8-919B-9B8AC1611EA5Q36646948-7FDE9FE7-94F3-4AD9-8B4D-D52913118558Q36865020-6920BE5D-492B-4AEC-9913-7D2EDEE001D7Q36907570-4D539EF0-2DBC-490F-9E8F-048ACBC54AB0Q36908335-52561E84-B89F-477D-9EF3-0D0517700DB7Q37053186-CE37763D-5E7D-4485-A8CC-C0802E8E6165Q37148990-9E6984EB-FF47-4DC2-A910-21F33F577484Q37261835-159DF856-9600-4ADE-B403-F76510266354Q37287883-38F5315A-1F12-4DE4-B447-FF88B5ED1D63
P2860
Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Histopathological and molecula ...... c, N-myc, TrkC, and anaplasia.
@en
Histopathological and molecula ...... c, N-myc, TrkC, and anaplasia.
@nl
type
label
Histopathological and molecula ...... c, N-myc, TrkC, and anaplasia.
@en
Histopathological and molecula ...... c, N-myc, TrkC, and anaplasia.
@nl
prefLabel
Histopathological and molecula ...... c, N-myc, TrkC, and anaplasia.
@en
Histopathological and molecula ...... c, N-myc, TrkC, and anaplasia.
@nl
P2093
P2860
P356
P1476
Histopathological and molecula ...... yc, N-myc, TrkC, and anaplasia
@en
P2093
Chi V Dang
Duncan Stearns
Kenneth Cohen
Krista Summers
Peter C Burger
Yunyue Wang
P2860
P304
P356
10.1093/JNEN/63.5.441
P577
2004-05-01T00:00:00Z